Insurers rejected one-third of new prescriptions for specialty oral anticancer medications ordered for patients with blood ...

In a recent transaction, Grigorios Siokas, the Chief Executive Officer of Cosmos Health Inc. (NASDAQ:COSM), acquired 51,414 shares of the company's common stock. The shares were purchased at a price ...

The global plant-based API market is expected to experience robust growth, with a projected value of USD 30,084.8 million in ...

4. Research from The Journal of Phytopharmacology highlights that ginger-raisin wine has antibacterial properties, making it ...

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

Inhibikase Therapeutics, Inc.’s IKT share price has dipped by 31.43%, which has investors questioning if this is right time ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

Swedish immuno-oncology firm Alligator Bioscience today announced that clinical data for its 4-1BB agonist, ATOR-1017 ...

Researchers from the University of Sharjah have identified a common herb, Artemisia herba-alba, as a potential natural ...

LUND, SE / ACCESS Newswire / January 29, 2025 / Alligator Bioscience (STO:ATORX) Publication validates encouraging clinical ...

Despite progress, significant disparities in cancer drug access persist globally, with low-income nations struggling to ...

Scientists from McGill University have discovered how certain microbes create powerful drugs such as antibiotics and cancer ...